Systemic sclerosis (scleroderma): open trials in Czechia

1 open trial has a site in Czechia. Registry data; only the trial team decides who can take part.

NCT07115745
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Fakultni Nemocnice Motol a Homolka, Prague · Revmatologicky Ustav, Prague 2
Registry updated 2026-07-14

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases